BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Immunology

Everest Medicines Announces First Prescription of VELSIPITY® for Ulcerative Colitis in Macau, Marking a Key Milestone in Asia

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...

December 13, 2024 | News

ADELA Phase III Trial Combines Elacestrant and Everolimus to Tackle Advanced ER+/HER2- Breast Cancer with ESR1 Mutations

ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breas...

December 13, 2024 | News

AstraZeneca and MSD LYNPARZA Shows Sustained Survival Benefit at Six Years in High-Risk Early Breast Cancer

87.5% of patients treated with LYNPARZA were alive at six years vs. 83.2% in the comparator arm First and only PARP inhibitor to improve survival in...

December 12, 2024 | News

Ono Pharmaceutical Partners with Congruence Therapeutics to Advance Oncology Drug Discovery

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that it has entered into a drug discove...

December 09, 2024 | News

Innovent and HUTCHMED Secure Conditional Approval in China for TYVYT® and ELUNATE® Combo in Advanced Endometrial Cancer

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

December 04, 2024 | News

Allink Biotherapeutics Secures $42 Million Series A Funding to Drive Global Expansion of Next-Gen ADC and Bispecific Antibody Therapies

Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutic...

November 29, 2024 | News

Kelun-Biotech Secures China’s First Approval for TROP2-Directed ADC Sacituzumab Tirumotecan for Advanced Triple-Negative Breast Cancer

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from ...

November 28, 2024 | News

Lunit Partners with Mexico's Salud Digna to Advance AI-Driven Cancer Diagnostics Across Latin America

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a strategic partnership with&nbs...

November 28, 2024 | News

QIAGEN’s QIAcuityDx Digital PCR System Approved by ARTG to Enhance Clinical Diagnostics Across Australia and New Zealand

Provides absolute quantitation, essential for precise monitoring of low-abundance targets in clinical diagnostics Enhances lab effic...

November 26, 2024 | News

Akeso's Penpulimab and Anlotinib Combo Accepted by NMPA for First-Line Advanced Liver Cancer Treatment

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accep...

November 25, 2024 | News

Hanmi Showcases Promising Progress in BH3120 Immunotherapy at SITC 2024

Hanmi unveils tiral in progress poster on BH3120 at the Society for Immunotherapy of Cancer (SITC) in the U.S.Phase 1 trial is progressing smoothly, with n...

November 25, 2024 | News

Mongolian Health Officials Tour SD Biosensor Facilities in Korea to Strengthen Infectious Disease Collaboration

A team of officials from the National Center for Communicable Diseases, Mongolia (NCCD), had a tour around the Cheongju and Jeungpyeong Factori...

November 21, 2024 | News

SK Biopharmaceuticals Partners with KIRAMS to Advance Radiopharmaceutical Cancer Therapies Using Actinium-225

SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates...

November 19, 2024 | News

BeiGene Rebrands as BeOne Medicines, Embracing a United Vision to Defeat Cancer Globally

The new name reflects a bold vision to eradicate cancer by leveraging the transformative power of global collaboration and multi-sectoral partn...

November 18, 2024 | News

Stay Connected